250 results on '"Chakraborty, Praloy"'
Search Results
2. Exercise-Induced QRS Prolongation in Brugada Syndrome: Implications for Improving Disease Phenotyping and Diagnosis
3. Potential consequences of cardioneuroablation for vasovagal syncope: A call for appropriately designed, sham-controlled clinical trials
4. Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
5. Sudden cardiac death due to ventricular arrhythmia in diabetes mellitus: A bench to bedside review
6. Restoration of calcium release synchrony: A novel target for heart failure and ventricular arrhythmia
7. Preoperative, Perioperative and CCU Care in Primary Electrical Disorders of the Heart
8. Correction: Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast
9. Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast
10. The neurometabolic axis: A novel therapeutic target in heart failure
11. Uncoupling cytosolic calcium from membrane voltage by transient receptor potential melastatin 4 channel (TRPM4) modulation: A novel strategy to treat ventricular arrhythmias
12. Protein kinase A: A potential marker of sympathovagal imbalance in heart failure
13. Impaired Cardiac AMPK (5′‐Adenosine Monophosphate‐Activated Protein Kinase) and Ca 2+ ‐Handling, and Action Potential Duration Heterogeneity in Ibrutinib‐Induced Ventricular Arrhythmia Vulnerability
14. Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton’s Tyrosine Kinase Inhibitor Acalabrutinib
15. Autonomic Nervous System and Cardiac Metabolism: Links Between Autonomic and Metabolic Remodeling in Atrial Fibrillation
16. Effect of Low-Level Tragus Stimulation on Cardiac Metabolism in Heart Failure with Preserved Ejection Fraction: A Transcriptomics-Based Analysis
17. Review of: "From Psychostasis to the Discovery of Cardiac Nerves: The Origins of the Modern Cardiac Neuromodulation Concept"
18. Acute effects of Dantrolene on the mechanical performance of myopathic human hearts
19. Reply to the Editor— Cardioneuroablation: Excessive Risk or Excessive Fear?
20. Synchronizing systolic calcium release with azumolene in an experimental model
21. Use of Wearable Technology and Deep Learning to Improve the Diagnosis of Brugada Syndrome
22. The validity of current implantable cardioverter-defibrillator guidelines in a real-world population of adults with congenital heart disease: A single-center experience
23. Impaired Cardiac AMPK (5'-Adenosine Monophosphate-Activated Protein Kinase) and Ca2+-Handling, and Action Potential Duration Heterogeneity in Ibrutinib-Induced Ventricular Arrhythmia Vulnerability.
24. Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice
25. Non-invasive Vagus Nerve Simulation in Postural Orthostatic Tachycardia Syndrome
26. Impact of Catheter Ablation for Atrial Arrhythmias on Repeat Cardioversion in Adults With Congenital Heart Disease
27. Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia
28. Safety and Long-term Outcomes of Defibrillator Therapy in Patients With Right-Sided Implantable Cardiac Devices in Adults With Congenital Heart Disease
29. The rationale for repurposing funny current inhibition for management of ventricular arrhythmia
30. Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats
31. Linking cellular energy state to atrial fibrillation pathogenesis: Potential role of adenosine monophosphate–activated protein kinase
32. Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome
33. Uncoupling cytosolic calcium from membrane voltage by transient receptor potential channel (TRPM4) modulation: A novel strategy to treat ventricular arrhythmias
34. Noninvasive low-level tragus stimulation attenuates inflammation and oxidative stress in acute heart failure
35. PO-02-179 DYNAMICS OF VENTRICULAR ACTIVATION DURING EXERCISE IN PATIENTS WITH BRUGADA SYNDROME: IMPLICATIONS FOR IMPROVING DISEASE PHENOTYPING AND DIAGNOSIS
36. PO-03-226 MACHINE LEARNING IDENTIFIES FEATURES OF ARRHYTHMOGENIC QRS FRAGMENTATION IN HUMAN CARDIOMYOPATHY: IMPLICATIONS FOR IMPROVING AND AUTOMATING RISK STRATIFICATION
37. PO-04-158 INTRACARDIAC ECHOCARDIOGRAPHY GUIDES ANATOMICAL ISTHMUS ABLATION IN PATIENTS WITH VENTRICULAR TACHYCARDIA AND REPAIRED TETRALOGY OF FALLOT
38. Automated Quantification of Abnormal QRS Peaks From High‐Resolution ECGs Predicts Late Ventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 5‐Year Prospective Multicenter Study
39. An Unusual Genetic Observation in a Case of Short-Coupled PVC-Triggered Ventricular Fibrillation
40. The role of autonomic denervation in the success of atrial fibrillation ablation: Can pulsed-field ablation provide the answer?
41. Aging-associated susceptibility to stress-induced ventricular arrhythmogenesis is attenuated by tetrodotoxin
42. IDSL.UFA Assigns High-Confidence Molecular Formula Annotations for Untargeted LC/HRMS Data Sets in Metabolomics and Exposomics
43. Paricalcitol Attenuates Metabolic Syndrome-Associated Heart Failure through Enhanced Mitochondrial Fusion
44. Oral Anticoagulants and Drug Interaction
45. Role of Purkinje‒muscle junction in early ventricular fibrillation in a porcine model: Beyond the trigger concept
46. PO-661-05 USE OF WEARABLE TECHNOLOGY AND DEEP LEARNING IN IMPROVING THE DIAGNOSIS OF BRUGADA SYNDROME THROUGH AUTOMATED BRUGADA TYPE 1 MONITORING
47. PO-642-08 40 YEAR OUTCOME OF THE CORRIDOR SURGERY FOR PAROXYSMAL ATRIAL FIBRILLATION
48. PO-668-06 AUTOMATED QUANTIFICATION OF ABNORMAL LOW-AMPLITUDE QRS PEAKS FROM HIGH-RESOLUTION ECGS PREDICTS LATE VENTRICULAR ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY: A 5-YEAR PROSPECTIVE MULTICENTER STUDY
49. Smart-watching the heart: Ready now or a way to go?
50. PO-05-174 EFFECTS OF TWO GENERATIONS OF BRUTON’S TYROSINE KINASE INHIBITORS ON ARRHYTHMOGENIC VENTRICULAR REMODELING
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.